Europska Unija - hrvatski - EMA (European Medicines Agency)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hipofiza i hipotalamusni hormoni i analozi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Europska Unija - hrvatski - EMA (European Medicines Agency)

sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cjepiva - hexyon (dtap-ipv--hb hib) je indiciran za primarne i booster cijepljenje dojenčadi i male djece od 6 tjedana starosti protiv difterije, tetanusa, protiv pertusisa, hepatitisa b, poliomijelitisa i invazivnih bolesti uzrokovane haemophilus influenzae tip b (hib). korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Europska Unija - hrvatski - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekcije respiratornih sincicijskih virusa - cjepiva - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Europska Unija - hrvatski - EMA (European Medicines Agency)

bayer animal health gmbh - имидаклоприд, моксидектин - antiparazitski proizvodi, insekticidi i repelenti - dogs; cats; ferrets - dogsfor psi koji pate od ili sklone, mješoviti parazitskih infekcija:prevencija i liječenje invazija buha (ctenocephalides feliz),liječenje ugriza uši (trichodectes velikog psa),liječenje ушного grinje infestacije (otodectes cynotis), саркоптозе (uzrokovane sarcoptes bolesti opcije. velikog psa), demodectic šuge (uzrokovane демодекс канис),prevenciju srčanog crva bolesti (l3 i l4 larve srčani crvi),liječenje kruži микрофилярии (srčane crve),za liječenje kožnih dirofilariosis (stadija zrelih дирофилярий repens)prevenciju kožnih dirofilariosis (Л3 ličinke дирофилярий repens),smanjenje kruži микрофилярии (srčane repens),prevencija angiostrongylosis (Л4 ličinke i nezreli odrasli angiostrongylus vasorum),liječenje angiostrongylus vasorum i crenosoma vulpis,prevencija spirocercosis (spirocerca лупи),liječenje eucoleus (suen. capillaria) boehmi (odrasli),liječenje oka crva thelazia callipaeda (odrasli),za liječenje infekcija probavnog trakta hookworms (Л4 larve, nezreli odrasli i odrasli Тохосага canis, ancylostoma сатпит i uncinaria stenocephala, imago toxascaris leonina i trichuris vulpis). proizvod se može koristiti kao dio strategije liječenja alergije dermatitisa buha (fad). catsfor mačke pate od ili sklone, mješoviti parazitskih infekcija:prevencija i liječenje invazija buha (ctenocephalides feliz),liječenje ушного grinje infestacije (otodectes cynotis),liječenje notoedric mangan (notoedres cati u),liječenje lungworm eucoleus aerophilus (suen. capillaria aerophila) (za odrasle),prevenciji bolesti lungworm (Л3/Л4 larve aelurostrongylus abstrusus),liječenje lungworm aelurostrongylus abstrusus (odrasli),liječenje oka crva thelazia callipaeda (odrasli),za prevenciju srčanog crva bolesti (l3 i l4 larve srčani crvi),za liječenje infekcija probavnog trakta hookworms (Л4 larve, nezreli odrasli i odrasli Тохосага cati i infestacije ancylostoma tubaeforme). proizvod se može koristiti kao dio strategije liječenja alergije dermatitisa buha (fad). ferretsfor prekapati, pate od ili sklone, mješoviti parazitskih infekcija:prevencija i liječenje invazija buha (ctenocephalides feliz),prevenciju srčanog crva bolesti (l3 i l4 ličinke srčani crvi).

Europska Unija - hrvatski - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - živi rekombinantni turkey herpes virus (rhvt / nd) povezan s stanicom, koji eksprimira fuzijski protein newcastle bolesti virusa d-26 lentogenog soja - imunomodulatori za aves živih virusnih cjepiva - chicken; embryonated eggs - za aktivne imunizacije 18 dana-starog эмбрионами kokošjih jaja ili dnevne pilića za smanjenje smrtnosti i kliničkih znakova, uzrokovane virusa Ньюкаслской bolesti i smanjiti smrtnost, klinički simptomi i lezije uzrokovane Марека bolesti zaraze s фенотипом "вирулентный".

Europska Unija - hrvatski - EMA (European Medicines Agency)

retrophin europe ltd - kolesku kiselinu - metabolizam, urođene pogreške - bile i jetrena terapija - Холевая kiselina ФГК indiciran za liječenje prirođenih pogrešaka primarnih žučnih kiselina sinteza, kod djece od jednog mjeseca za kontinuirano doživotno liječenje do punoljetnosti, uključuje sljedeće jedan ферментных grešaka:balzam 27-hidroksilaze (predstavljajući kao церебротендинальный ксантоматоз, СТХ) deficit;2- (ili alfa-) methylacyl-koa racemase (protein amacr) deficit;kolesterol-7-alfa-hidroksilaze (cyp7a1) deficit.

Europska Unija - hrvatski - EMA (European Medicines Agency)

laboratorios hipra, s.a. - živjeti аттенуированного virus infektivne бурсальной bolesti (ibdv), procijediti 1052 - imunomodulatori za ptice, domaće peradi, živa virusna cjepiva, ptica zaraznih бурсальной bolesti virus (bolest Гамборо) - chicken; embryonated chicken eggs - za aktivne imunizacije 1-dnevne pilića i эмбрионами tovnih jaja za smanjenje kliničkih manifestacija i gubitka фабрициевой torbi, nošena vrlo вирулентные ptica zaraznih бурсальной bolesti virusne infekcije.

Europska Unija - hrvatski - EMA (European Medicines Agency)

orion corporation - tasipimidine sulfate - other hypnotics and sedatives - psi - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.